Observational Study on Disease Severity, Evaluation Tools and the Long Term Impact of Each Treatment Strategy in the Daily Clinical Practice in Patients With Moderate to Severe Active Crohn's Disease (Protocol P06484)

Merck Sharp & Dohme LLC0 sites71 target enrollmentNovember 2011

ConditionsCrohn Disease

InterventionsPhysician standard-of-care

DrugsPhysician standard-of-care

Overview

Phase: Not Applicable
Intervention: Physician standard-of-care
Conditions: Crohn Disease
Sponsor: Merck Sharp & Dohme LLC
Enrollment: 71
Primary Endpoint: Record of treatment strategy followed
Status: Completed
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Similar Trials

Overview

Brief Summary

This is an observational study to determine the prevalence of moderate to severe Crohn's disease (CD) among patients with active CD and to evaluate existing therapeutic trends in a standard clinical practice.

Registry

clinicaltrials.gov

Start Date

November 2011

End Date

January 2015

Last Updated

11 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Merck Sharp & Dohme LLC

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Arms & Interventions

Participants

All participants enrolled

Intervention: Physician standard-of-care

Outcomes

Primary Outcomes

Record of treatment strategy followed

Time Frame: Week 0 to 2 years

Percentage of Crohn's disease participants among the study population with a Crohn's Disease Activity Index (CDAI) score of 220-450 at the enrollment to the study.

Time Frame: Week 0

Change in the CDAI score during the observational period

Time Frame: Week 0 to 2 years